Showing results (111-120 of 219) with videos related to
Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasmsFarhad Ravandi, Ahmed Aribi, Susan O'Brien, et al.Oncotarget|March 22, 2021
STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.International Journal of Hematology|February 22, 2018
Characteristics and outcome of chronic myeloid leukemia patients with E255K/V BCR-ABL kinase domain mutationsKiran Naqvi, Jorge E Cortes, Raja Luthra, et al.Leukemia & Lymphoma|February 28, 2022
Clinical outcome of allogeneic stem cell transplantation in patients with B-cell lymphoid malignancies following treatment with targeted small molecule inhibitorsAkash Mukherjee, Denái R Milton, Elias J Jabbour, et al.Clinical Lymphoma & Myeloma|December 16, 2005
T-cell prolymphocytic leukemia: a single-institution experienceFarhad Ravandi, Susan O'Brien, Dan Jones, et al.Patient Preference and Adherence|August 29, 2023
Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic LeukemiaXiaoxiao Lu, Bruno Emond, Laura Morrison, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemiaWilliam Wierda, Susan O'Brien, Sijin Wen, et al.Molecular Cancer Research : MCR|March 4, 2015
Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL CellsUri Rozovski, Srdana Grgurevic, Carlos Bueso-Ramos, et al.Blood|October 22, 2009
Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemiaJohn C Byrd, Thomas J Kipps, Ian W Flinn, et al.Cancer Immunology Research|September 19, 2019
Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic LeukemiaPriyanka Banerjee, Ronghua Zhang, Cristina Ivan, et al.Pageof 22